Medivizor

Title of notification

Here comes the notification
X
 
icon
icon
diabetes mellitus | Research | Treatment | 10 pages | source: BMC endocrine disorders | Added Jun 02, 2022

Can canagliflozin improve insulin resistance and internal fat tissue in patients with type 2 diabetes better than metformin?

This study assessed the effects of canagliflozin (Invokana) therapy on body composition, glucose control, insulin resistance, and systemic (whole body) inflammation in patients with newly-diagnosed type 2 diabetes (T2D) compared to metformin (Glucophage). The data showed that canagliflozin therapy reduced visceral fat tissue, and improved blood glucose, insulin resistance, and systemic inflammation in these patients.

icon
rheumatoid arthritis | Research | 10 pages | source: Arthritis Research & Therapy | Added Jun 01, 2022

Can disease flare be predicted following remission and treatment withdrawal in patients with early rheumatoid arthritis?

This study identified predictors of disease flare in patients with early, active rheumatoid arthritis (RA) that had stopped methotrexate (MTX; Otrexup) and/or abatacept (Orencia) treatment after clinical remission was achieved at 12 months. The data showed that patient function (HAQ-DI) and bone erosion based on magnetic resonance imaging (MRI) scans predicted disease flare at 6 months and 12 months after treatment withdrawal.

icon
icon
diabetes mellitus | Research | Lifestyle | 10 pages | source: The American Journal of Clinical Nutrition | Added May 31, 2022

Can a low-carbohydrate diet affect insulin-resistant lipoprotein metabolism?

This study determined the effect of varying carbohydrate and saturated fat dietary contents on cardiovascular disease (CVD) risk factors during weight-loss maintenance. The authors concluded that restriction of carbohydrates provided improved insulin resistance on lipoprotein metabolism, without unwanted side effects on low-density lipoprotein (LDL) cholesterol or inflammation.

icon
icon
diabetes mellitus | Research | Treatment | 10 pages | source: Diabetes, Obesity and Metabolism | Added May 10, 2022

Does metformin use decrease the risk of hospitalization and mortality from COVID-19?

This study assessed the link between metformin (Glucophage) use in hospitalized and non-hospitalized patients with diabetes and different outcomes due to coronavirus disease 2019 (COVID-19). The study showed that metformin use was associated with a protective effect in COVID-19 outcomes in patients with type 2 diabetes (T2D).

icon
icon
diabetes mellitus | Research | Lifestyle | 10 pages | source: Nutrients | Added May 08, 2022

Evaluating the effect of whole grain consumption in blood sugar control of patients with diabetes.

This study evaluated the effect of whole grain consumption in glycaemic (blood sugar) control of patients with diabetes. The data showed that whole grain consumption was beneficial for the control of blood glucose levels in these patients.

icon
icon
rheumatoid arthritis | Research | Treatment | 10 pages | source: Frontiers in immunology | Added Apr 29, 2022

How effective is denosumab treatment in patients with rheumatoid arthritis?

This review evaluated the effectiveness of denosumab (Prolia) on bone mineral density (BMD) and joint destruction in patients with rheumatoid arthritis (RA). The authors concluded that denosumab treatment was linked to increased BMD and reduced joint destruction in patients with RA.

icon
diabetes mellitus | Research | 10 pages | source: Diabetes Care | Added Apr 29, 2022

Can fenofibrate therapy reduce the need for retinal laser treatment in patients with diabetic eye disease?

This review evaluated the effect of prolonged fenofibrate (Tricor) treatment on the need for retinal laser treatment for diabetic eye disease in patients with type 2 diabetes (T2D). The data showed a reduced need for retinal laser treatment in these patients compared to placebo.

icon
diabetes mellitus | Research | 10 pages | source: Diabetes, Obesity and Metabolism | Added Mar 22, 2022

Do patients with diabetes have a different antibody response to COVID-19 vaccines compared to healthy individuals?

This study evaluated the antibody response and side effects associated with COVID-19 vaccines administration in patients with type 1 (T1D) and type 2 diabetes (T2D), people without diabetes. The data showed similar immune responses in patients with and without diabetes after the second COVID-19 vaccine, regardless of glucose control.

icon
icon
diabetes mellitus | Research | Treatment | 10 pages | source: Diabetes Care | Added Mar 20, 2022

Can high-frequency spinal cord stimulation provide relief to patients with painful diabetic nerve disease?

This study evaluated the long-term impact of 10-kHz spinal cord stimulation (SCS) in patients with painful diabetic neuropathy (PDN; nerve disease) and refractory symptoms. The data supported the use of 10-kHz SCS for important, durable pain relief over 12 months in these patients.

icon
icon
diabetes mellitus | Research | Treatment | 10 pages | source: Diabetes Research and Clinical Practice | Added Feb 15, 2022

Comparing chiglitazar and sitagliptin effectiveness on glucose variations, insulin resistance and inflammation levels in patients with type 2 diabetes.

This study compared the effectiveness of chiglitazar (Bilessglu) and sitagliptin (Januvia) on glycemic (blood glucose) variations, insulin resistance, and inflammation levels in patients with type 2 diabetes (T2D). The data showed that chiglitazar treatment was more effective at improving insulin resistance and inflammation compared with sitagliptin in these patients.

View

Conditions

Category

  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon

Was this helpful?